Difference between revisions of "Team:Aachen/Lab/Methanol/Monocistronic Diversity Library"
(→Design) |
|||
(6 intermediate revisions by one other user not shown) | |||
Line 2: | Line 2: | ||
__NOTOC__ | __NOTOC__ | ||
− | Within our polycistronic | + | Within our polycistronic methanol conversion construct the expression of the four genes ''mdh'', ''hps'', ''phi'' and ''xpk'' is controlled by the constitutive promoter [http://parts.igem.org/Part:BBa_J23119 BBa_J23119]. To tune the expression levels of the genes for a more efficient expression system it is neccessary to control them seperately. |
Line 20: | Line 20: | ||
− | Because we expected the promoter BBa_J23119 to be the strongest within the Anderson Promoter Library, we chose this one to always control the bottleneck enzyme Mdh in our circuit design. Diversity is introduced by varying the promoters for the three remaining genes ''hps'', ''phi'' and ''xpk''. We decided on a set of four promoters from the Anderson Library: | + | Because we expected the promoter [http://parts.igem.org/Part:BBa_J23119 BBa_J23119] to be the strongest within the Anderson Promoter Library, we chose this one to always control the bottleneck enzyme Mdh in our circuit design. Diversity is introduced by varying the promoters for the three remaining genes ''hps'', ''phi'' and ''xpk''. We decided on a set of four promoters from the Anderson Library: |
− | * BBa_J23100 | + | * [http://parts.igem.org/Part:BBa_J23100 BBa_J23100] |
− | * BBa_J23104 | + | * [http://parts.igem.org/Part:BBa_J23104 BBa_J23104] |
− | * BBa_J23110 | + | * [http://parts.igem.org/Part:BBa_J23110 BBa_J23110] |
− | * BBa_J23119 | + | * [http://parts.igem.org/Part:BBa_J23119 BBa_J23119] |
Line 39: | Line 39: | ||
{{Team:Aachen/Figure|Aachen_Mono1.png|title=Monocistronic diversity library RDP circuit|subtitle=The circuit is composed by RDP parts. The black labled sites demonstrate, where we planed to introduce diversity by adding equimolar promoter part mixes during the assembly. | {{Team:Aachen/Figure|Aachen_Mono1.png|title=Monocistronic diversity library RDP circuit|subtitle=The circuit is composed by RDP parts. The black labled sites demonstrate, where we planed to introduce diversity by adding equimolar promoter part mixes during the assembly. | ||
− | (#FO4B#: Kanamycin anchor, #XYD9#: BBa_J23119 RDP part, #PRDW#: BBa_K1585210 RDP part, #PLTB#: trp terminator RDP part, #VO4C#: BBa_K1585211 RDP part, #8AMS#: BBa_B1006 RDP part, #ZALV#: BBa_K1585212 RDP part, #HTSR#: BBa_B1002 RDP part, #ZR1Q#: BBa_K1585213.BBa_B0015 RDP part, #OZD1#: high copy cap) | + | (#FO4B#: Kanamycin anchor, #XYD9#: [http://parts.igem.org/Part:BBa_J23119 BBa_J23119] RDP part, #PRDW#: [http://parts.igem.org/Part:BBa_K1585210 BBa_K1585210] RDP part, #PLTB#: trp terminator RDP part, #VO4C#: [http://parts.igem.org/Part:BBa_K1585211 BBa_K1585211] RDP part, #8AMS#: [http://parts.igem.org/Part:BBa_B1006 BBa_B1006] RDP part, #ZALV#: [http://parts.igem.org/Part:BBa_K1585212 BBa_K1585212] RDP part, #HTSR#: [http://parts.igem.org/Part:BBa_B1002 BBa_B1002] RDP part, #ZR1Q#: [http://parts.igem.org/Part:BBa_K1585213 BBa_K1585213].[http://parts.igem.org/Part:BBa_B0015 BBa_B0015] RDP part, #OZD1#: high copy cap) |
|size=large}} | |size=large}} | ||
Line 47: | Line 47: | ||
{{Team:Aachen/Figure|Aachen_Mono2.png|title=Precursor sets|subtitle=One precursor set always consists of: | {{Team:Aachen/Figure|Aachen_Mono2.png|title=Precursor sets|subtitle=One precursor set always consists of: | ||
− | # BBa_B0034 + CDS RDP part | + | # [http://parts.igem.org/Part:BBa_B0034 BBa_B0034] + CDS RDP part |
# the appropriate terminator RDP part | # the appropriate terminator RDP part | ||
# promoter RDP part | # promoter RDP part | ||
Line 58: | Line 58: | ||
{{Team:Aachen/Figure|Aachen_Mono3.png|title=Assembly Strategy of the precursor plasmids|subtitle=First, the RDP part carrying the RBS and CDS is assembled to the cap. After the terminator part has been added, the reaction mix is split up into four. Respectively one of the four different promoter parts is added to one of the four reaction mix fractions. After finishing the assembly with an appropriate cap, you will receive four different precursor plasmids from the four different reaction mixes. | {{Team:Aachen/Figure|Aachen_Mono3.png|title=Assembly Strategy of the precursor plasmids|subtitle=First, the RDP part carrying the RBS and CDS is assembled to the cap. After the terminator part has been added, the reaction mix is split up into four. Respectively one of the four different promoter parts is added to one of the four reaction mix fractions. After finishing the assembly with an appropriate cap, you will receive four different precursor plasmids from the four different reaction mixes. | ||
− | (BBa_J23100, BBa_J23104, BBa_J23110 and BBa_J23119 represent the four different Anderson promoters)|size=large}} | + | ([http://parts.igem.org/Part:BBa_J23100 BBa_J23100], [http://parts.igem.org/Part:BBa_J23104 BBa_J23104], [http://parts.igem.org/Part:BBa_J23110 BBa_J23110] and [http://parts.igem.org/Part:BBa_J23119 BBa_J23119] represent the four different Anderson promoters)|size=large}} |
Line 67: | Line 67: | ||
! Precursor !! description | ! Precursor !! description | ||
|- | |- | ||
− | | BBa_K1585210.Trp*.BBa_J23100 || ''mdh''.AP00 precursor | + | | [http://parts.igem.org/Part:BBa_K1585210 BBa_K1585210].Trp*.[http://parts.igem.org/Part:BBa_J23100 BBa_J23100] || ''mdh''.AP00 precursor |
|- | |- | ||
− | | BBa_K1585210.Trp*.BBa_J23104 || ''mdh''.AP04 precursor | + | | BBa_K1585210.Trp*.[http://parts.igem.org/Part:BBa_J23104 BBa_J23104] || ''mdh''.AP04 precursor |
|- | |- | ||
− | | BBa_K1585210.Trp*.BBa_J23110 || ''mdh''.AP10 precursor | + | | BBa_K1585210.Trp*.[http://parts.igem.org/Part:BBa_J23110 BBa_J23110] || ''mdh''.AP10 precursor |
|- | |- | ||
− | | BBa_K1585210.Trp*.BBa_J23119 || ''mdh''.AP19 precursor | + | | BBa_K1585210.Trp*.[http://parts.igem.org/Part:BBa_J23119 BBa_J23119] || ''mdh''.AP19 precursor |
|- | |- | ||
− | | BBa_K1585211.BBa_B1006.BBa_J23100 || ''hps''.AP00 precursor | + | | [http://parts.igem.org/Part:BBa_K1585211 BBa_K1585211].[http://parts.igem.org/Part:BBa_B1006 BBa_B1006].BBa_J23100 || ''hps''.AP00 precursor |
|- | |- | ||
| BBa_K1585211.BBa_B1006.BBa_J23104 || ''hps''.AP04 precursor | | BBa_K1585211.BBa_B1006.BBa_J23104 || ''hps''.AP04 precursor | ||
Line 83: | Line 83: | ||
| BBa_K1585211.BBa_B1006.BBa_J23119 || ''hps''.AP19 precursor | | BBa_K1585211.BBa_B1006.BBa_J23119 || ''hps''.AP19 precursor | ||
|- | |- | ||
− | | BBa_K1585212.BBa_B1002.BBa_J23100 || ''phi''.AP00 precursor | + | | [http://parts.igem.org/Part:BBa_K1585212 BBa_K1585212].[http://parts.igem.org/Part:BBa_B1002 BBa_B1002].BBa_J23100 || ''phi''.AP00 precursor |
|- | |- | ||
| BBa_K1585212.BBa_B1002.BBa_J23104 || ''phi''.AP04 precursor | | BBa_K1585212.BBa_B1002.BBa_J23104 || ''phi''.AP04 precursor | ||
Line 102: | Line 102: | ||
* ''hps'' precursor mix: equimolar mix of the four different BBa_K1585211.BBa_B1006.BBa_J231XX precursor RDP parts | * ''hps'' precursor mix: equimolar mix of the four different BBa_K1585211.BBa_B1006.BBa_J231XX precursor RDP parts | ||
* ''phi'' precursor mix: equimolar mix of the four different BBa_K1585212.BBa_B1002.BBa_J231XX precursor RDP parts | * ''phi'' precursor mix: equimolar mix of the four different BBa_K1585212.BBa_B1002.BBa_J231XX precursor RDP parts | ||
− | (#FO4B#: kanamycin cap, #XYD9#: BBa_J23119 RDP part, #ZR1Q#: BBa_K1585213.BBa_B0015 RDP part, #OZD1#: high copy cap) | + | (#FO4B#: kanamycin cap, #XYD9#: [http://parts.igem.org/Part:BBa_J23119 BBa_J23119] RDP part, #ZR1Q#: [http://parts.igem.org/Part:BBa_K1585213 BBa_K1585213].[http://parts.igem.org/Part:BBa_B0015 BBa_B0015] RDP part, #OZD1#: high copy cap) |
|size=large}} | |size=large}} | ||
− | The | + | The assembly product is supposed to be transformed into an appropriate expression strain (e.g. ''E. coli'' BL21 Gold DE3). By testing the growth performance, the resulting transformants can be screened. Strains harboring more efficient methanol conversion plasmids are expected to perform better in presence of methanol than others. |
=Results= | =Results= | ||
Line 118: | Line 118: | ||
! Precursor !! Results !! Plasmid ID | ! Precursor !! Results !! Plasmid ID | ||
|- | |- | ||
− | | BBa_K1585210.Trp*.BBa_J23100 || Failure || - | + | | [http://parts.igem.org/Part:BBa_K1585210 BBa_K1585210].Trp*.[http://parts.igem.org/Part:BBa_J23100 BBa_J23100] || Failure || - |
|- | |- | ||
− | | BBa_K1585210.Trp*.BBa_J23104 || Success || #OX44# | + | | BBa_K1585210.Trp*.[http://parts.igem.org/Part:BBa_J23104 BBa_J23104] || Success || #OX44# |
|- | |- | ||
− | | BBa_K1585210.Trp*.BBa_J23110 || Failure || - | + | | BBa_K1585210.Trp*.[http://parts.igem.org/Part:BBa_J23110 BBa_J23110] || Failure || - |
|- | |- | ||
− | | BBa_K1585210.Trp*.BBa_J23119 || Success || #DNRY# | + | | BBa_K1585210.Trp*.[http://parts.igem.org/Part:BBa_J23119 BBa_J23119] || Success || #DNRY# |
|- | |- | ||
− | | BBa_K1585211.BBa_B1006.BBa_J23100 || Success || #ERZK# | + | | [http://parts.igem.org/Part:BBa_K1585211 BBa_K1585211].[http://parts.igem.org/Part:BBa_B1006 BBa_B1006].BBa_J23100 || Success || #ERZK# |
|- | |- | ||
| BBa_K1585211.BBa_B1006.BBa_J23104 || Failure || - | | BBa_K1585211.BBa_B1006.BBa_J23104 || Failure || - | ||
Line 134: | Line 134: | ||
| BBa_K1585211.BBa_B1006.BBa_J23119 || Failure || - | | BBa_K1585211.BBa_B1006.BBa_J23119 || Failure || - | ||
|- | |- | ||
− | | BBa_K1585212.BBa_B1002.BBa_J23100 || Success || #931O# | + | | [http://parts.igem.org/Part:BBa_K1585212 BBa_K1585212].[http://parts.igem.org/Part:BBa_B1002 BBa_B1002].BBa_J23100 || Success || #931O# |
|- | |- | ||
| BBa_K1585212.BBa_B1002.BBa_J23104 || Success || #EZYZ# | | BBa_K1585212.BBa_B1002.BBa_J23104 || Success || #EZYZ# | ||
Line 158: | Line 158: | ||
=Outlook= | =Outlook= | ||
− | After characterizing the Mdh activity in our polycistronic strain and considering it's reduced growth rate, we think that the monocistronic expression strategy is worth exploring. | + | After characterizing the Mdh activity in our polycistronic strain and considering it's reduced growth rate, we think that the monocistronic expression strategy is worth exploring. Creating a plasmid with atuned expression levels of the genes will provide more knowledge about the interactions between the enzymes and can help searching for an optimal way to make bacteria take up methanol efficiently. |
=References= | =References= |
Latest revision as of 00:26, 19 September 2015